Find uplifting stories about heroes, innovations, and solutions
7865 results for "blindness treatment"
Millions of older adults facing wet age-related macular degeneration now have a newly approved treatment option after years of development. Outlook Therapeutics' Lytenava offers hope to those battling this leading cause of vision loss in seniors.
A revolutionary gene therapy called Luxturna has restored vision to hundreds of people born legally blind from a rare inherited disease. One young patient saw snowfall for the first time after receiving the treatment that proved inherited diseases can be reversed.
A Boston biotech company has treated the first person with a gene therapy designed to reverse cellular aging in the human body. The groundbreaking treatment targets serious eye diseases that cause blindness by resetting damaged cells to a younger, healthier state.
Scientists in Finland developed a gentle heat treatment that helps aging eyes repair themselves before dry macular degeneration causes vision loss. Human trials begin this spring for a condition affecting 20 million Americans.
A Belgian startup just earned FDA breakthrough status for a brain implant that bypasses damaged eyes entirely to restore functional vision. Clinical trials in blind volunteers could begin as soon as summer 2027.
Abu Dhabi is funding the UAE's first gene therapy clinical trial to treat a rare inherited eye disease that leads to blindness. The groundbreaking treatment could transform lives for patients with no current cure.
Scientists have discovered that a simple vitamin supplement could help prevent glaucoma, the leading cause of irreversible blindness affecting 80 million people worldwide. The breakthrough came from identifying vulnerable cells in the eye that respond positively to vitamin B3 treatment.
UK researchers found that tocilizumab, a common arthritis medication, helped people with depression who didn't respond to standard antidepressants. The breakthrough could offer hope to millions struggling with treatment-resistant depression.
A new UCLA study shows an intensive five-day magnetic brain stimulation protocol works as well as the traditional six-week treatment for depression. This breakthrough could help thousands of patients who struggle to commit to months of clinic visits.
Four promising new treatments could reach patients this spring, offering fresh hope for people battling hard-to-treat conditions. From the first-ever medication for a chronic liver infection to an at-home Alzheimer's treatment, these therapies represent real progress for patients who've been waiting.
A Shanghai neurologist discovered a potential Alzheimer's therapy after his 90-year-old mother improved cognitively following ultrasound treatment for a different condition. His trial now tests high-intensity focused ultrasound as a standalone treatment, a promising departure from mainstream research.
A new HIV pill taken just once a week appears as effective as daily treatment in major studies. Over six million South Africans currently on daily HIV medication could benefit from simpler treatment.
A groundbreaking study will use advanced imaging to personalize cancer treatment, potentially cutting unnecessary therapy while helping more patients access care. The collaboration could transform how doctors decide when prostate cancer patients have received enough treatment.
For the first time in decades, Americans with treatment-resistant depression have two powerful new options that work differently than anything before. Clinical trials show these breakthrough treatments are helping patients who've struggled for years finally find relief.
UK scientists created a simple blood test that tells doctors whether breast cancer treatment will work before therapy even begins. The breakthrough could spare patients from months of ineffective drugs and help them find treatments that actually work.
Patients with chronic lymphocytic leukemia now have a new treatment option that doesn't require chemotherapy and allows time off from treatment. The FDA approved the first all-oral, fixed-duration therapy for this common adult leukemia.
Scientists have enrolled the first patient in a groundbreaking trial to find effective treatments for the deadly Bundibugyo strain of Ebola in the Democratic Republic of Congo. The trial brings hope to a region where more than 1,400 people have been infected since May, with currently no approved treatments available.
BestCare Treatment Services broke ground on Oregon's only residential treatment center designed specifically for Latino men struggling with substance use disorder. The culturally tailored facility will provide care entirely in Spanish, addressing critical language and cultural barriers that often prevent people from seeking help.
The FDA is accelerating reviews of three psychedelic medications for depression and PTSD, moving promising mental health treatments closer to patients who desperately need them. Millions struggling with treatment-resistant conditions could soon have groundbreaking new options.
Men with spreading prostate cancer can now postpone harsh hormone therapy for over two years thanks to a targeted radiation treatment that leaves healthy tissue untouched. A quarter of patients showed no tumors after treatment.
Showing 20 of 7865